Volume 8; Issue 2

Main
Pharmacogenetics
Volume 8; Issue 2

Pharmacogenetics

Volume 8; Issue 2

1

Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers

Matthias, Christoph, Bockm??hl, Ulrike, Jahnke, Volker, Jones, Peter W., Hayes, John D., Alldersea, Julie, Gilford, Janice, Bailey, Lisa, Bath, Joanna, Worrall, Stephen F., Hand, Philip, Fryer, Anthon

Journal:

Pharmacogenetics

Year:

1998

File:

PDF, 893 KB

1998

2

Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population

Singleton, A. B., Thomson, J. H., Morris, C. M., Court, J. A., Lloyd, S., Cholerton, S.

Journal:

Pharmacogenetics

Year:

1998

File:

PDF, 367 KB

1998

3

High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI-GSTM10/0 genotypes

Rojas, M., Alexandrov, K., Cascorbi, I., Brockm??ller, J., Likhachev, A., Pozharisski, K., Bouvier, G., Auburtin, G., Mayer, L., Kopp-Schneider, A., Roots, I., Bartsch, H.

Journal:

Pharmacogenetics

Year:

1998

File:

PDF, 892 KB

1998

4

Deficiency of cytosolic arylamine N-acetylation in the domestic cat and wild felids caused by the presence of a single NAT1-like gene

Trepanier, Lauren A., Cribb, Alastair E., Spielberg, Stephen P., Ray, Kunal

Journal:

Pharmacogenetics

Year:

1998

File:

PDF, 1.12 MB

1998

5

The NAT2* slow acetylator genotype is associated with bladder cancer in Taiwanese, but not in the Black Foot Disease endemic area population

Su, H. Jenny, Guo, Yueliang Leon, Lai, Ming-Derg, Huang, Jin-ding, Cheng, Yawen, Christiani, David C.

Journal:

Pharmacogenetics

Year:

1998

File:

PDF, 310 KB

1998

6

Ultrarapid metabolism of sparteine

Bathum, Lise, Johansson, Inger, Ingelman-Sundberg, Magnus, H??rder, Mogens, Br??sen, Kim

Journal:

Pharmacogenetics

Year:

1998

File:

PDF, 434 KB

1998

7

Correctness of prediction of the CYP2D6 phenotype confirmed by genotyping 47 intermediate and poor metabolizers of debrisoquine

Sachse, Christoph, Brockm??ller, J??rgen, Hildebrand, Michael, M??ller, Katrin, Roots, Ivar

Journal:

Pharmacogenetics

Year:

1998

File:

PDF, 307 KB

1998

8

Post-transcriptional regulation of human microsomal epoxide hydrolase

Laurenzana, Elizabeth M., Hassett, Christopher, Omiecinski, Curtis J.

Journal:

Pharmacogenetics

Year:

1998

File:

PDF, 971 KB

1998

9

Use of heterologously expressed human cytochrome P4501A2 to predict tacrine-fluvoxamine drug interaction in man

Becquemont, Laurent, Le Bot, Marie A., Richeb, Christian, Funck-Brentano, Christian, Jaillon, Patrice, Beaune, Philippe

Journal:

Pharmacogenetics

Year:

1998

File:

PDF, 758 KB

1998

10

An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians

Ibeanu, Gordon C., Blaisdell, Joyce, Ghanayem, Burhan I., Beyeler, Christine, Benhamou, Simone, Bouchardy, Christine, Wilkinson, Grant R., Dayer, Pierre, Daly, Ann K., Goldstein, Joyce A.

Journal:

Pharmacogenetics

Year:

1998

File:

PDF, 646 KB

1998

11

Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism

M??enp????, Jukka, Hall, Stephen D., Ring, Barbara J., Strom, Stephen C., Wrighton, Steven A.

Journal:

Pharmacogenetics

Year:

1998

File:

PDF, 1.50 MB

1998